as on February 7, 2026 at 7:59 am IST
Day's Low
Day's High
1.98%
Downside
4.31%
Upside
52 Week's Low
52 Week's High
66.37%
Downside
97.80%
Upside
Check Lyell Immunopharma, Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$529.0M
EPS (TTM)
-10.6075
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.78
Industry PE ratio
-2.8179250720461093
PEG Ratio
0EBITDA
-184.4M
Revenue (TTM)
41.0K
Profit Margin
0.00%
Return On Equity TTM
-75.75%
Track how Lyell Immunopharma, Inc P/E has moved over time to understand its valuation trends.
Lyell Immunopharma, Inc in the last 5 years
Lowest (-132.44x)
December 31, 2022
Industry (-2.82x)
February 6, 2026
Today (-1.78x)
February 6, 2026
Highest (-2.02x)
September 30, 2025
Today’s Price to Earnings Ratio: -1.78x
Compare market cap, revenue, PE, and other key metrics of Lyell Immunopharma, Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $529.0M | NA | -1.78 | 0.00% | |
| BUY | $47.7B | 100.62% | 1246.03 | 1.36% | |
| BUY | $122.3B | 113.14% | 33.56 | 31.35% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 53.64% | 18.28 | 32.13% |
The Lyell Immunopharma, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Lyell Immunopharma, Inc investment value today
Current value as on today
₹1,95,984
Returns
₹95,984
(+95.98%)
Returns from Lyell Immunopharma, Inc Stock
₹92,470 (+92.47%)
Dollar Returns*
₹3,513 (+3.51%)
Based on 10 analysts
70.00%
Buy
30.00%
Hold
0.00%
Sell
Based on 10 analysts, 70% of analysts recommend a 'BUY' rating for Lyell Immunopharma, Inc. Average target price of $29.67
Get share price movements and forecasts by analysts on Lyell Immunopharma, Inc.
What analysts predicted
23.32%UPSIDE
Target Price
$29.67
Current Price
$22.75
Analyzed by
10 Analysts
Target
$29.67
Lyell Immunopharma, Inc target price $29.67, a slight upside of 23.32% compared to current price of $22.75. According to 10 analysts rating.
Search interest for Lyell Immunopharma, Inc Stock has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 7.0K → 15.0K (in $), with an average increase of 29.6% per quarter
Price Rise
![]()
In the last 6 months, LYEL stock has moved up by 100.0%
Profit Spike
![]()
Netprofit is up for the last 4 quarters, -191.93M → -38.84M (in $), with an average increase of 100.0% per quarter
Best in 1 Year
![]()
In the last 1 year, LYEL has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 39.3% return, outperforming this stock by 104.7%
| Organisation | Lyell Immunopharma, Inc |
| Headquarters | 201 Haskins Way, South San Francisco, CA, United States, 94080 |
| Industry | Services |
| CEO | Dr. Lynn Seely M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Prof. Stanley R. Riddell M.D. | Founder & Scientific Advisor |
Dr. Crystal L. Mackall M.D. | Founder & Scientific Advisor |
Nellie Dillery | Director of Accounting |
Dr. Gary K. Lee Ph.D. | Chief Scientific Officer |
Mr. Mark A. Meltz J.D. | General Counsel & Corporate Secretary |
Mr. Bryan Selby | Senior Vice President of Clinical Development Operations |
Dr. Richard D. Klausner M.D. | Founder & Executive Chairman |
Mr. Stephen J. Hill | Chief Operating Officer |
Ms. Ann Tomlin | Chief Human Resources Officer |
Dr. Lynn Seely M.D., Ph.D. | Interim Principal Financial Officer, Principal Executive Officer, President, CEO & Director |
Lyell Immunopharma, Inc share price today is $22.75 as on at the close of the market. Lyell Immunopharma, Inc share today touched a day high of $23.73 and a low of $22.3.
Lyell Immunopharma, Inc share touched a 52 week high of $45 on and a 52 week low of $7.65 on . Lyell Immunopharma, Inc stock price today i.e. is closed at $22.75,which is 49.44% down from its 52 week high and 197.39% up from its 52 week low.
Lyell Immunopharma, Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Lyell Immunopharma, Inc (LYEL) shares with as little as ₹90.662 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹906.62 in Lyell Immunopharma, Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Lyell Immunopharma, Inc share’s latest price of $22.75 as on February 7, 2026 at 2:29 am IST, you will get 0.4396 shares of Lyell Immunopharma, Inc. Learn more about
fractional shares .